ArticleJournal of cancer research and clinical oncology2024

Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes.

Zitao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.